Form D · Pharmaceuticals

NORTHWEST BIOTHERAPEUTICS INC

Bethesda, MD · CIK 0001072379

Offering snapshot reported Sep 14, 2020 · SEC filing

Reported sold
$0
Offering amount: $2.59M
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 28, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 14, 2020Initial$0No comparison2SEC filing
Jan 10, 2018Initial$880,000No comparison0SEC filing
May 17, 2017Initial$52,000No comparison1SEC filing
Mar 15, 2016Initial$10,000,000No comparison5SEC filing
Dec 9, 2010Amendment$395,000$395,000vs Dec 7, 20107SEC filing
Dec 7, 2010Initial$0No comparison7SEC filing
Apr 17, 2006PaperNot reportedNo comparisonNot reported
Feb 9, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
Yes
Sales commissions
$0
Finders' fees
$0
Form D file number
021-375444

Source: Form D, filed Sep 14, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Susan Bayh Director
J Cofer Black Director
Cofer Black Director
Marnix L Bosch Executive
Alton L Boynton Director, Executive
Robert A Farmer Director
Leslie J Goldman Executive
Jerry J Jasinowski Director
Navid Malik Director
Linda F Powers Director, Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
4800 Montgomery Lane Suite 800
Bethesda, MD, 20814